For the Inventor, By the Inventor

Enter assignee name

Lake Forest, CA, United States of America

3F Therapeutics, Inc.

USPTO Granted Patents = 31

% Expired Patents = 29.0

CIPO Patents = 8

EPO Patents = 3

Forward Citations = 10,519

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Keith E Myers (10 out of 30 patents)

Rodolfo C Quijano (9 out of 21 patents)

James L Cox (7 out of 16 patents)

4. Hosheng Tu (6 out of 153 patents)

5. Douglas S Cali (5 out of 21 patents)

6. Christine Nguyen (3 out of 4 patents)

7. Patrick M McCarthy (2 out of 32 patents)

8. Than Nguyen (2 out of 23 patents)

9. Jason Artof (2 out of 7 patents)

10. Demetrio Bicer (2 out of 4 patents)

11. Hosheng Tu (2 out of 87 patents)

12. Bjarne Bergheim (1 out of 41 patents)

13. Menno Kalmann (1 out of 24 patents)

14. Oleg Svanidze (1 out of 2 patents)

15. Rodolfo C Quijano Quijano (1 out of 1 patent)

Core Competencies:

Laser Cutting

Implantable Medical Device

Heart Valve Prosthesis

Embolic Protection

Percutaneous Delivery

Minimally Invasive

Prosthetic Heart Valve

Blood Flow Regulation

Expandable Medical Implant

Stentless Valve Bioprosthesis

Atrioventricular Heart Valve

Semilunar Heart Valve

31 patents: Sort by Forward Citations

1. 8043450 - Method of cutting tissue using a laser (2011-10-25),

2. RE42857 - Method of laser cutting pericardial tissue for use with an implantable medical device (2011-10-17),

3. RE42818 - Method of cutting material for use in implantable medical device (2011-10-10),

4. 7842084 - Method and systems for sizing, folding, holding, and delivering a heart valve prosthesis (2010-11-30),

5. 7604650 - Method and assembly for distal embolic protection (2009-10-20),

6. 7594974 - Method of cutting material for use in implantable medical device (2009-09-29),

7. 7530995 - Device for reduction of pressure effects of cardiac tricuspid valve regurgitation (2009-05-12),

8. 7410499 - Valve holder (2008-08-12),

9. 7159593 - Methods for reduction of pressure effects of cardiac tricuspid valve regurgitation (2007-01-09),

10. 7101396 - Minimally invasive valve replacement system (2006-09-05),

11. 7044966 - Minimally invasive valve replacement system (2006-05-16),

12. 7041132 - Percutaneously delivered heart valve and delivery means thereof (2006-05-09),

13. 7037333 - Prosthetic heart valve (2006-05-02),

14. 6979350 - Methods for regulating the flow of blood through the blood system (2005-12-27),

15. 6974464 - Supportless atrioventricular heart valve and minimally invasive delivery systems thereof (2005-12-13),

Company Overview

3F Therapeutics, Inc. is a biotechnology company based in Lake Forest, California, focused on developing innovative therapies for patients with unmet medical needs. The company specializes in advanced drug delivery systems and regenerative medicine, leveraging cutting-edge research to create solutions that enhance treatment efficacy and patient outcomes. With a commitment to scientific excellence, 3F Therapeutics aims to transform the landscape of therapeutic options through its proprietary technologies and collaborative research initiatives.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

31 Patents

#12 in Lake Forest, CA

#2,614 in California

#10,936 in US

#21,284 in the World

Lake Forest, CA, United States of America

3F Therapeutics, Inc.

Forward Citations = 10,519

18 inventors:

Keith E Myers (10 out of 30 patents)

Rodolfo C Quijano (9 out of 21 patents)

James L Cox (7 out of 16 patents)

4. Hosheng Tu (6 out of 153 patents)

5. Douglas S Cali (5 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: 3F Therapeutics, Inc.. Retrieved from https://idiyas.com/company/3f-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…